U.S. federal trademark · Serial No. 97272570 · Reg. No. 7414532
providing medical and scientific research information in the fields of pharmaceuticals and biotechnology
oligonucleotide-conjugate based therapies, oligonucleotide-antibody conjugate based therapies, and oligonucleotide-antibody fragment conjugate based therapies for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, neuromuscular, rare muscle diseases, cardiomyopathies, heart muscle diseases, muscular dystrophies, muscle atrophy, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.